From Tabs to Jabs: Practical Tips to provide Long-Acting Injectable Buprenorphine

Saturday, April 26, 2025

4:15 PM – 5:30 PM

Presenter(s)

Judy S. Chertok, MD

Associate Professor
University of Pennsylvania
Bala Cynwyd, Pennsylvania
Rachael Truchil, MD, MPH

Associate Professor
University of Pennsylvania
Philadelphia, Pennsylvania
Stephen Holt, MD, MS, FACP, FASAM

Associate Professor of Medicine
Yale School of Medicine
New Haven, Connecticut
Irina (Era) V. Kryzhanovskaya, MD

Associate Professor
UCSF
San Francisco, California

This session will equip clinicians with the essential medical knowledge and practical tips to implement and expand long-acting injectable buprenorphine (LAIB) treatment in their practices. Participants will leave with a comprehensive understanding of LAIB options, implementation strategies, and a tailored action plan to expand access in their settings.

Learning Objectives:

Learners will be able to:

Compare and contrast the available long-acting injectable buprenorphine (LAIB) options.
Recognize the patient characteristics that may make LAIB an ideal treatment choice.
Describe the logistical considerations and operational strategies for the provision of LAIB in outpatient settings.

Disclosure(s):

Judy S. Chertok, MD: No financial relationships to disclose

Rachael Truchil, MD, MPH: No financial relationships to disclose

Stephen Holt, MD, MS, FACP, FASAM: No financial relationships to disclose

Irina (Era) V. Kryzhanovskaya, MD: No financial relationships to disclose